CTNM
CTNM
US21217B1008
Contineum Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
503.37M EUR
616.48M EUR
488.27M EUR
426.57M EUR
Enterprise Value
265.87M EUR
608.35M EUR
475.06M EUR
359.22M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-6.98x
--
--
--
Price to Sales
--
--
--
--
Price to Book
2.1x
2.57x
1.95x
1.63x
EV/Revenue
--
--
--
--
EV/EBITDA
-4.03x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-6.98%
-8.67%
-11.81%
-9.63%
ende